NASDAQ · STTK
Shattuck Labs, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for STTK: Nov 5, 2026
Shattuck Labs, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.1. The reported EPS for the same quarter last year was $-0.14.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.10 | $-0.08 | $-0.13 | 6 |
| Dec 2026 | $-0.11 | $-0.09 | $-0.13 | 6 |
| Mar 2027 | $-0.11 | $-0.09 | $-0.14 | 4 |
| Jun 2027 | $-0.12 | $-0.09 | $-0.15 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks · Fintel- RTTNews · Oct 1, 10:39 AM EDTShattuck Advances SL-325 Into Phase 2 Hidradenitis Suppurativa Trial(RTTNews) – On Thursday, Shattuck Labs (STTK) announced plans to evaluate SL-325 in a Phase 2 clinical trial in patients with moderate to severe hidradenitis suppurativa (HS).
- The Motley Fool · Aug 24, 6:23 PM EDTWhat Shattuck Labs Stock Topped the Market on MondayOne of them initiated coverage.
- Zacks · Aug 20, 12:00 PM EDTShattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Aug 13, 9:55 AM EDTWall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to TradeThe consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- RTTNews · Aug 11, 5:38 PM EDTShattuck Labs Incurs Higher Q2 Loss; To Advance SL-325 In Phase 2b For Crohn's Disease In Q3 '26(RTTNews) – Shattuck Labs Inc. (STTK), a clinical-stage biotechnology company, on Tuesday announced financial results for the second quarter, noting a higher loss due to increased operating expenses.
- The Motley Fool · Jul 24, 6:27 PM EDTWhy Shattuck Labs Stock Flew Nearly 5% Higher on FridayHe was encouraged by the progress of the company's SL-325.
- RTTNews · Jun 14, 10:02 PM EDTTop Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch(RTTNews) – Among Friday's notable biotech movers were TherapeuticsMD, which is evaluating a strategic review process; Sensei Biotherapeutics, supported by optimism surrounding a key clinical catalyst expected in the second half of 2026; and Alumis, which is advancing its lead th
- RTTNews · Jun 10, 5:16 AM EDTShattuck Labs Prices $75 Mln Offering Of Shares And Warrants; Stock Down(RTTNews) – Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company, priced its previously announced public offering of 10.88 million shares at a price of $4 per share and pre-funded warrants to purchase up to 7.87 million shares at a price of $3.9999 per pre-funded wa
- Fintel · Apr 28, 9:24 AM EDTShattuck Labs (STTK) Price Target Increased by 24.00% to 12.65The average one-year price target for Shattuck Labs (NasdaqGS:STTK) has been revised to $12.65 / share. This is an increase of 24.00% from the prior estimate of $10.20 dated April 12, 2026. The price target is an average of many targets provided by analysts. T
- Fintel · Apr 27, 8:04 PM EDTCantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK) with Overweight RecommendationFintel reports that on April 27, 2026, Cantor Fitzgerald initiated coverage of Shattuck Labs (NasdaqGS:STTK) with a Overweight recommendation. Analyst Price Forecast Suggests 31.78% Upside
- Fintel · Mar 26, 10:23 PM EDTShattuck Labs (STTK) Price Target Increased by 37.93% to 10.20The average one-year price target for Shattuck Labs (NasdaqGS:STTK) has been revised to $10.20 / share. This is an increase of 37.93% from the prior estimate of $7.40 dated February 21, 2026. The price target is an average of many targets provided by analysts.
- The Motley Fool · Mar 6, 5:02 PM ESTWhy Shattuck Labs Stock Soared More Than 53% Higher This WeekThe biotech published its final earnings report and business covering 2025.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Shattuck Labs, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.